The US regulator has cleared Eohilia (formerly TAK-721), an oral suspension formulation of the well-established steroid drug budesonide ... while first-in-class lung cancer therapy Exkivity ...

TAK-721 – provisionally known as Eohilia - is an oral suspension formulation of the well-established steroid drug budesonide that ... they are either best-in-class or first-in-class therapies.

The patient's budesonide was discontinued before the first infusion of dexamethasone. The patient's jaundice improved after cycles one and three of chemotherapy and steroid treatment, but cycles ...

The Annals of Pharmacotherapy. 2009;43(3):519-527.

Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel anti-CD19 chimeric antigen receptor (CAR) T cell therapy, obecabtagene ...

It’s the sound of the massive steel door slamming closed, followed by the sliding home of the bolt and the snicking of the padlock, that has never left me. And then there was the smell – overcooked ...